A - Human Necessities
61
K
A61K 39/13 (2006.01)
Patent
CA 2662051
The standard dose of polio vaccines contains 40 D-antigen units of inactivated poliovirus type 1 (Mahoney), 8 D-antigen units of inactivated poliovirus type 2 (MEF-1), and 32 D-antigens units of inactivated poliovirus type 3 (Saukett). The present invention teaches that reduced doses of inactivated poliovirus can maintain an adequate or improved level of protection against polio.
La présente invention concerne le domaine des vaccins pour protéger contre la polio et, en particulier, des vaccins de combinaison pour protéger contre la polio, la diphtérie, le tétanos et la coqueluche. L'invention concerne particulièrement des vaccins comprenant un poliovirus inactivé (IPV) à dose réduite, qui peut conserver un niveau suffisant ou amélioré de protection contre la polio.
de Hemptinne Herve
Duchene Michel
Mary Anne
Sonveaux Marc
Glaxosmithkline Biologicals S.a.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1346922